INCREASED EXPRESSION OF MUC18 CORRELATES WITH THE METASTATIC PROGRESSION OF MOUSE PROSTATE ADENOCARCINOMA IN THE TRAMP MODEL
Authors:
- 1 May 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 173 (5) , 1778-1783
Abstract
Purpose: The transgenic adenocarcinoma mouse prostate (TRAMP) model is a paradigm that closely mimics the progression of clinical prostate cancer. We have previously reported that MUC18, a ...Keywords
This publication has 14 references indexed in Scilit:
- Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology CommitteeCancer Research, 2004
- Ectopical expression of human MUC18 increases metastasis of human prostate cancer cellsGene, 2004
- Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse modelThe Prostate, 2003
- Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progressionGene, 2001
- Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissuesThe Prostate, 2001
- Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic abilityGene, 2001
- Pathologic progression of autochthonous prostate cancer in the TRAMP modelProstate Cancer and Prostatic Diseases, 1999
- A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cellsProceedings of the National Academy of Sciences, 1998
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995
- Identification of bone marrow micrometastases in patients with prostate cancerCancer, 1994